Skip to main content

Johnson & Johnson’s stock jumps after earnings top estimates and company raises guidance

J&J's Medical-technologies business benefits as patients catch up on procedures they put off during the pandemic.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.